Education
About Us
Working with TipRanks
Follow Us
Voyageur Pharmaceuticals (VYYRF)
OTHER OTC:VYYRF
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -1.57K | C$ -2.19K | C$ -2.91K | C$ -2.25K | C$ -1.48K |
| Operating Income | C$ -1.70M | C$ -1.22M | C$ -1.75M | C$ -2.05M | C$ -848.94K |
| EBITDA | C$ -1.71M | C$ -1.22M | C$ -1.75M | C$ -2.05M | C$ -1.12M |
| Net Income | C$ -1.71M | C$ -1.40M | C$ -1.75M | C$ -2.05M | C$ -1.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 165.57K | C$ 2.08K | C$ 31.56K | C$ 812.97K | C$ 2.97K |
| Total Assets | C$ 2.60M | C$ 2.16M | C$ 2.10M | C$ 2.57M | C$ 1.28M |
| Total Debt | C$ 40.00K | C$ 40.00K | C$ 25.52K | C$ 42.08K | C$ 268.41K |
| Net Debt | C$ -125.57K | C$ 37.91K | C$ -6.04K | C$ -770.89K | C$ 265.44K |
| Total Liabilities | C$ 2.15M | C$ 727.88K | C$ 630.83K | C$ 660.64K | C$ 968.85K |
| Stockholders' Equity | C$ 449.96K | C$ 1.44M | C$ 1.46M | C$ 1.91M | C$ 306.33K |
| Cash Flow | |||||
| Free Cash Flow | C$ -302.29K | C$ -991.25K | C$ -2.00M | C$ -2.09M | C$ -434.13K |
| Operating Cash Flow | C$ -302.29K | C$ -991.25K | C$ -1.72M | C$ -1.65M | C$ -272.19K |
| Investing Cash Flow | C$ -165.96K | C$ -174.72K | C$ -274.15K | C$ -432.08K | C$ -151.79K |
| Financing Cash Flow | C$ 631.73K | C$ 1.14M | C$ 1.21M | C$ 2.90M | C$ 351.34K |
Voyageur Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.